Israel Active

(Thanks to NoCamels.com) Israel’s XPAND has a cool solution for “lazy eye” – a condition affecting around 4 percent of children. XPAND’s Amblyz eyeglasses obstruct the strong eye in automatic, intermittent intervals using an electronic shutter attached to one of the lenses.

Researchers at Ben-Gurion University have discovered that a single dose of methylphenidate (MPH) - medication used to treat attention deficit hyperactivity disorder - can reduce the risk of falls in the elderly.

(Thanks to NoCamels.com) Professor Illana Gozes of Tel Aviv University has created a new peptide (short protein) called NAP that latest trials indicate could treat neuro-degenerative diseases such as Alzheimer’s, ALS or Parkinson’s.

(Thanks to NoCamels.com) Israeli start-up CoreBone has developed a method of performing bone implants (spinal, dental etc.) using corals that are grown in the laboratory rather than harvested from the sea. CoreBone produces high quality corals to encourage bone growth without damaging the ecology.

Researchers in Israel and San Francisco have been able to switch off a memory pathway in the brains of rats responsible for alcohol dependency. Tests on humans are expected soon. The results may also lead to the treatment of nicotine craving.

Israel’s RegeneCure has developed an innovative synthetic membrane for those needing dental implants. Alternative animal-tissue-derived collagen membranes risk being contaminated from pathogens. RegeneCure’s membrane also degrades slowly, giving the natural bone more time to regenerate.

(Thanks to Israel21c) Field of Vision, a new series by photographer Vardi Kahana, documents the people touched by Eye from Zion, an Israeli organization that provides free ocular medical treatment to needy populations around the world.

(Thanks to Israel21c) Over the past few weeks I have been reporting only headline stories of wounded Syrians being treated in Israeli hospitals. Here is an amazing in-depth feature about what happens on the front lines (at the border and at the hospital).

One of the exhibits at the Presidential Conference in Jerusalem spotlighted on Israel’s top research into the human brain.

The Hebrew University is to establish a center for pharmaceutical research and treatment of children. Its focus includes incurable genetic diseases, building new models for testing drugs for children and synthesizing new molecules suited for children, despite being unprofitable.